Evidence map›Paper›PMID 36229662›Full record

ArticleNature biomedical engineering2022

A potent antibiotic-loaded bone-cement implant against staphylococcal bone infections.

Sumana Ghosh, Mau Sinha, Ritwik Samanta, Suresh Sadhasivam, Anamika Bhattacharyya, Ashis Nandy, Swamini Saini, Nupur Tandon, Himanshi Singh, Swati Gupta and 11 more

Open access · greenAbstract read
In one paragraph

Article in Nature biomedical engineering, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
15.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 74 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. [Frontier research on smart delivery biomaterials in the field of oral tissue engineering].Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology · 2026
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 3 institutions in 2 countries.

Sumana Ghosh *Vyome Therapeutics Inc., Princeton, NJ, USA.
Mau Sinha *Vyome Therapeutics Inc., Princeton, NJ, USA.
Ritwik SamantaVyome Therapeutics Inc., Princeton, NJ, USA.
Suresh SadhasivamVyome Therapeutics Inc., Princeton, NJ, USA.
Anamika BhattacharyyaVyome Therapeutics Inc., Princeton, NJ, USA.
Ashis NandyVyome Therapeutics Inc., Princeton, NJ, USA.
Swamini SainiVyome Therapeutics Inc., Princeton, NJ, USA.
Nupur TandonVyome Therapeutics Inc., Princeton, NJ, USA.
Himanshi SinghVyome Therapeutics Inc., Princeton, NJ, USA.
Swati GuptaVyome Therapeutics Inc., Princeton, NJ, USA.
Anjali ChauhanVyome Therapeutics Inc., Princeton, NJ, USA.
Keerthi Kumar AavulaVyome Therapeutics Inc., Princeton, NJ, USA.
Sneha Susan VargheseDepartment of Biotechnology, Indian Institute of Technology, Kharagpur, India.
Pujie ShiCenter for Engineered Therapeutics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Sudip GhoshDepartment of Biotechnology, Indian Institute of Technology, Kharagpur, India.
Mukesh Kumar GargVyome Therapeutics Inc., Princeton, NJ, USA.
Tanmoy SahaCenter for Engineered Therapeutics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Aparna PadhyeCenter for Engineered Therapeutics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0001-6169-7372
Shamik GhoshVyome Therapeutics Inc., Princeton, NJ, USA. shamik.ghosh@vyometx.com.
Hae Lin JangCenter for Engineered Therapeutics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. hjang@bwh.harvard.edu.ORCID http://orcid.org/0000-0003-3923-9732
Shiladitya SenguptaCenter for Engineered Therapeutics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. ssengupta2@bwh.harvard.edu.ORCID http://orcid.org/0000-0002-8065-5052
Vyome Biosciences (India) · INBrigham and Women's Hospital · USIndian Institute of Technology Kharagpur · IN

Funding

Whitlockite nanoparticle-based immunotherapy for bone metastasisR01CA236702 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI JANG, HAE LIN, SENGUPTA, SHILADITYA · 2019 to 2023
$2.7M
3D printed muscle-bone organ implant for treating large injuriesR01AR073135 · NIAMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DOKMECI, MEHMET REMZI, JANG, HAE LIN · 2018 to 2022
$2.2M
NCI NIH HHS R01 CA236702NIAMS NIH HHS R01 AR073135
6 · The paper itself

Abstract

New antibiotics should ideally exhibit activity against drug-resistant bacteria, delay the development of bacterial resistance to them and be suitable for local delivery at desired sites of infection. Here, we report the rational design, via molecular-docking simulations, of a library of 17 candidate antibiotics against bone infection by wild-type and mutated bacterial targets. We screened this library for activity against multidrug-resistant clinical isolates and identified an antibiotic that exhibits potent activity against resistant strains and the formation of biofilms, decreases the chances of bacterial resistance and is compatible with local delivery via a bone-cement matrix. The antibiotic-loaded bone cement exhibited greater efficacy than currently used antibiotic-loaded bone cements against staphylococcal bone infections in rats. Potent and locally delivered antibiotic-eluting polymers may help address antimicrobial resistance.

Indexed as

Anti-Bacterial AgentsBone CementsAnimalsBiofilmsProstheses and ImplantsRatsAnti-Bacterial AgentsBone Cements

Identifiers

PMID36229662
PMCPMC10101771
OpenAlexW4305014560

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.